-
Symbol
-
CBIO on Nasdaq
-
Investment type
-
Equity / Ordinary Shares, $0.001 par value per share
-
Latest Disclosed Ownership
-
3.12M shares
-
Security Ownership
-
20%
Shares, Excluding Options vs Price
Value, Excluding Options
Fairmount Funds Management LLC ownership in CRESCENT BIOPHARMA, INC. Ordinary Shares, $0.001 par value per share (CBIO)
2025-06-23 - Fairmount Funds Management LLC has filed an SCHEDULE 13D form with the Securities and Exchange Commission (SEC) disclosing ownership of 3.12M shares of CRESCENT BIOPHARMA, INC. Ordinary Shares, $0.001 par value per share (CBIO).
This represents 20% percent ownership of the company.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.